New Approach Needed For Bladder Cancer Biomarker
Country of origin: USA
Click for Full Details: www.biomedcentral.comThe clinical problem of bladder cancer is its high recurrence and progression, and that the most sensitive and specific means of monitoring is cystoscopy, which is invasive and has poor patient compliance. Biomarkers for recurrence and progression could make a great contribution, but in spite of decades of research, no biomarkers are commercially available with the requisite sensitivity and specificity.
In an article published in BMC Urology, Robert Hurst discusses the problems surrounding detection and monitoring of bladder cancer and the potential utility of a whole-genome approach using systems biology to develop a clinically effective biomarker panel.
Click for Full Details: www.biomedcentral.com
inPractice® Oncology June 2018
Cancer Research Network Measures March 2018
Orlive Surgical Broadcasts February 2018
ONCO Assist January 2018
Cancer.net mobile by ASCO January 2018
Chemo Calendar January 2018
Cancer Navigator January 2018
Oncology Nurse Advisor January 2018
Breast Cancer Survivor January 2018
Cancer Emergency Response Tool January 2018